NAFLD: Clinical Trials

1 trial for NAFLD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rifaximin in Fatty Liver Disease
Rifaximin - Nonalcoholic Fatty Liver Disease, NAFLD
Phase 4TerminatedImperial College London152011-05-012020-10-28

Narrower conditions

Inflammation (1)  ·  Insulin Resistance (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Digestive System Diseases (1)  ·  Fatty Liver (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Rifaximin (1)

Sponsors

Imperial College London (1)

Countries

United Kingdom (1)

Top investigators

Jeremy FL Cobbold, PhD (1)  ·  Mark R Thursz, MD (1)